Literature DB >> 29721935

Nanoparticles as Delivery Vehicles for the Treatment of Retinal Degenerative Diseases.

Yuhong Wang1,2, Ammaji Rajala1,2, Raju V S Rajala3,4,5,6.   

Abstract

Over the last few years, huge progress has been made in the understanding of molecular mechanisms underlying the pathogenesis of retinal degenerative diseases. Such knowledge has led to the development of gene therapy approaches to treat these devastating disorders. Non-viral gene delivery has been recognized as a prospective treatment for retinal degenerative diseases. In this review, we will summarize the constituent characteristics and recent applications of three representative nanoparticles (NPs) in ocular therapy.

Entities:  

Keywords:  Blindness; Lipid nanoparticles; Metal-based nanoparticles; Nanoparticles; Non-viral vectors; Ocular diseases; Polymer-based nanoparticles; Retinal degeneration

Mesh:

Substances:

Year:  2018        PMID: 29721935      PMCID: PMC6417423          DOI: 10.1007/978-3-319-75402-4_15

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  2 in total

1.  Therapeutic Benefits from Nanoparticles: The Potential Significance of Nanoscience in Retinal Degenerative Diseases.

Authors:  Raju V S Rajala
Journal:  J Mol Biol Ther       Date:  2019

Review 2.  Intranasal delivery in glioblastoma treatment: prospective molecular treatment modalities.

Authors:  Daniel E Morales; Shaker Mousa
Journal:  Heliyon       Date:  2022-05-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.